Peter Kalev
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- RNA modifications and cancer
- DNA Repair Mechanisms
- RNA Research and Splicing
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
Papers in
-
- DNA Repair Mechanisms 7
- Cancer-related gene regulation 3
- Epigenetics and DNA Methylation 3
- RNA modifications and cancer 2
- Protein Degradation and Inhibitors 2
- RNA Research and Splicing 2
- Mitochondrial Function and Pathology 2
- Oncology 3
- Co-authors
- Anna A. Sablina (5 shared papers)Iria Vázquez (2 shared papers)Dipanjan Chowdhury (3 shared papers)Michal Šimíček (2 shared papers)Rüveyda Dok (1 shared paper)Esther I. Hauben (1 shared paper)Layka Abbasi Asbagh (1 shared paper)Sandra Nuyts (1 shared paper)
- Journals
- Cancer Cell (2 papers)Journal of Medicinal Chemistry (2 papers)Cancer Research (2 papers)Radiation Research (1 paper)Cell Death and Differentiation (1 paper)
- Partner nations
- United StatesBelgiumBulgaria
In The Last Decade
Peter Kalev
14 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 76
- Cancer Research 407
- Molecular Biology 1.1k
- Otorhinolaryngology 54
- Oncology 324
- Cell Biology 106
Countries citing papers authored by Peter Kalev
This map shows the geographic impact of Peter Kalev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kalev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kalev more than expected).
Fields of papers citing papers by Peter Kalev
This network shows the impact of papers produced by Peter Kalev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kalev. The network helps show where Peter Kalev may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Kalev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 388 | |
| 2 | 2021 | 181 | |
| 3 | 2018 | 135 | |
| 4 | 2012 | 109 | |
| 5 | 2014 | 107 | |
| 6 | 2014 | 103 | |
| 7 | 2012 | 100 | |
| 8 | 2013 | 83 | |
| 9 | 2021 | 79 | |
| 10 | 2011 | 53 | |
| 11 | 2009 | 25 | |
| 12 | 2020 | 23 | |
| 13 | 2015 | 17 | |
| 14 | 2008 | 2 | |
| 15 | 2025 | 0 |
About Peter Kalev
Peter Kalev is a scholar working on Molecular Biology, Oncology, Cancer Research, Cell Biology and Virology, having authored 15 papers that have together received 1.4k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (7 papers), Cancer-related gene regulation (3 papers), Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (2 papers), Microtubule and mitosis dynamics (2 papers), Protein Degradation and Inhibitors (2 papers), RNA Research and Splicing (2 papers) and Mitochondrial Function and Pathology (2 papers). The work is most often cited by research in Cancer Research (407 citations), Molecular Biology (1.1k citations), Otorhinolaryngology (54 citations), Oncology (324 citations) and Cell Biology (106 citations). Peter Kalev has collaborated with scholars based in United States, Belgium and Bulgaria. Frequent co-authors include Anna A. Sablina, Iria Vázquez, Dipanjan Chowdhury, Michal Šimíček, Rüveyda Dok, Esther I. Hauben, Layka Abbasi Asbagh, Sandra Nuyts, Evert Jan Van Limbergen and Wen Ling Chen. Their work appears in journals such as Cancer Cell, Journal of Medicinal Chemistry, Cancer Research, Radiation Research and Cell Death and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.